Aurobindo Pharma
BSE 524804
6 stories, newest first.
- USFDA final approval received for Perampanel Tablets in 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg
- Subsidiary completes acquisition of A1 Biochem Group's contract research business
- Aurobindo arm A1 Biocheme USA Inc completes 100% acquisition of A1 Biocheme Labs LLC for USD 15.247 Mn
- Aurobindo's step-down arm A1 Biochem Labs allots shares and CCDs worth INR 33.80 crore, Apitoria stake down to 80%
- Step-down arm Acrotech launches ADQUEY (difamilast 1%) ointment in the U.S., sets up dermatology unit
- GST appellate order confirms Rs. 4,60,28,908 ITC demand for FY 2020-21; appeal planned
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.